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Background: Diabetic individuals have a largely increased risk of lower extremity amputation (LEA) compared with
non-diabetic patients. Prior systematic reviews of incidence of LEA have some limitations with respect to lack of
consensus in the definition of LEA, level of LEA (all, major, minor), and definition of source population (general
population or population with diabetes at risk). The purpose of our review is to evaluate the incidence of LEA in
the diabetic population and its differences with regard to sex, ethnicity, age, and regions; to compare the incidence
rate (IR) in the diabetic and non-diabetic population; and to investigate time trends.
Methods/design: We will perform a systematic literature search in MEDLINE, Embase, Web of Knowledge, and
publisher databases such as Journals@OVID and ScienceDirect. We will develop comprehensive systematic search
strategies according to established guidelines for meta-analyses of observational studies in epidemiology (the
MOOSE group). Two authors will independently screen abstracts and full text of all references on the basis of
inclusion criteria with respect to types of study, types of population, and the main outcome. We will exclude studies
if they report solely incidences of LEA among persons with diabetes mellitus when referring to the total population
(diabetic and non-diabetic) and not exclusively to the diabetic population. Data extraction and assessment of risk of
bias will be undertaken by two review authors working independently. We will assess incidence rate (IR) or cumulative
incidence (CumI), relative risk of amputations comparing the diabetic to non-diabetic populations, cause of LEA,
and type of diabetes. If we find subsets of studies to be homogeneous enough, we will perform meta-analyses for
incidence rates by Poisson generalized linear mixed models (GLMM).
Systematic review registration: PROSPERO CRD42015017809
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ProtocolBackground
The prevalence of diabetes mellitus has increased sub-
stantially and has reached 8.3 % in 2014 which corre-
sponds to 387 million patients globally [1]. This overall
increment leads to the growth in the number of individ-
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unless otherwise stated.arterial disease, peripheral neuropathy, and lower ex-
tremity amputation (LEA).
In the Western countries, LEA has frequently been
cited as a primary objective by health systems and
organization [2], and diabetic individuals still have a
largely increased LEA risk compared with non-diabetic
patients [3, 4]. According to Vamos et al. and Trautner
et al., people with diabetes have up to a 40-fold in-
creased risk of LEA when compared with the general
population, and also approximately half of all people
undergoing non-traumatic amputations are diagnosed
with diabetes [5, 6]. Avoidance of amputation should notl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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consequences (high costs due to repeated hospitaliza-
tions, rehabilitation, home care, and social-service sup-
port) but also due to quality-of-life issues [7].
A number of reviews have summarized the published
medical literature on the incidence of LEA in diabetic
and non-diabetic populations (Moxey et al. [8], Ephraim
et al. [9], Larsson et al. [10], Pernot et al. [11]). However,
all of these have some limitations, especially (1) lack of
consensus in the definition of “lower extremity amputa-
tion” with respect to the cause of LEA as well as in the
reporting of incidence of LEA (one or more events per
person), (2) level of LEA (all, major, minor), (3) with respect
to selection of the study population, and (4) definition
of source population (general population or population
with diabetes at risk).
Given the lack of systematic knowledge, we will con-
duct a first systematic review concerning incidence of
LEA in diabetic patients referred to a population at risk.
Objectives
The main objectives of this review are (1) to evaluate the
incidence of LEA in the diabetic population and differ-
ences between incidences of LEA with respect to sex,
ethnicity, age, and regions; (2) to compare incidence
rates of LEA in the diabetic and non-diabetic population;
and (3) to investigate time trends.
This systematic review is part of an ongoing national
initiative, aimed to evaluate time trends of amputation,
end-stage renal disease, blindness, stroke, myocardial in-
farction, and adverse perinatal outcome [12].
Methods and design




All population-based longitudinal studies using both
prospective and retrospective designs should be included
for this review.
Types of populations
The source populations should firstly be defined by offi-
cial statistics, which means e.g., all inhabitants of a de-
fined region or all insured persons of a statutory health
insurance. Secondly, all the included individuals with
diabetes (incident or prevalent) should be known or esti-
mated in a valid manner. Hence, source population
which we will study could be (1) general population, di-
vided into those with and those without diabetes, (2) all
individuals with prevalent diabetes within a defined
population, or (3) all individuals with incident diabetes
within a defined population.Individuals with diabetes can have type 1 diabetes, type
2 diabetes, or diabetes without definition of diabetes
type. We will also consider old diabetes classifications,
namely insulin-dependent (IDDM) and non-insulin-
dependent diabetes mellitus (NIDDM). Individuals with-
out diabetes will also be considered with the aim of
comparing incidences between diabetic und non-diabetic
populations.
Outcomes
The main outcome should be the incidence of LEA
among patients with diabetes mellitus (DM). The ana-
lysis of incidence LEA will be done according to the fol-
lowing parameters:
■ Epidemiologic incidence measures:
□ Incidence rate (IR)
□ Cumulative incidence (CumI)
■ Reporting incidence of LEA:
□ Person level (only one amputation per person).
□ Case level, e.g., from hospital data (on the same
admission only one amputation per person). This
could be several hospitalizations per person in the
same calendar year.
□ Procedure level (all amputations).
■ Level of LEA:
□ All (independent of level)
□ Major and minor amputations
Different definitions of amputations (major, minor, or
all) can be used in the studies. We will describe the re-
spective definitions of LEA level of these studies.
Moreover, we will consider secular time trends as well
as differences in the LEA risk between demographic vari-
ables (sex, ethnicity, age) and regions. Additionally, we will
investigate relative risks (RR), comparing the incidence of
LEA among populations with and without diabetes.
Information sources
We will perform a systematic literature search in
MEDLINE, Embase, Web of Knowledge, and publisher
databases such as Journals@OVID and ScienceDirect.
Moreover, we will use other resources to search poten-
tially eligible studies, such as reference lists of review
articles and relevant studies. We will contact authors
of such potential studies for full text if the full text is
otherwise not available.
Search strategies
We will develop comprehensive systematic search strat-
egies to fulfill the demand of conducting systematic re-
views according to predetermined protocols and
established guidelines for meta-analyses of observational
studies in epidemiology (the MOOSE group [14]).
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(high recall) and simultaneously, to identify only relevant
publications (high precision) and thus yielding a low
number needed to read (NNR) (minimizing subsequent
workload). The information retrieval will be based on a
search model structured by PICO components (see
Additional file 1). Some snowballing and berrypicking
strategies will be added to obtain a sufficient search
yield. The search strategies will be adapted and processed
by using the database-specific controlled vocabularies
(MeSH, EMTREE) and additional free text terms. In-
cluded search terms will be e.g., amputation, amputee
(search component “intervention”); lower extremity, foot,
feet, limb, etc. (search component “problem”); and epi-
demiology, prevalence, incidence, frequency, population
survey, survey data, administrative data, community data,
etc. (search component “epidemiologic studies”). The
search terms and components will be combined by using
Boolean operators and, when possible, by proximity oper-
ators. The search protocols will be published in a trans-
parent and reproducible manner.
All database records yielded by the search strategies
will be exported into EndNote, where remaining dupli-
cates will be removed manually.
Study selection process and inclusion and exclusion
criteria
Two authors will independently screen abstracts and titles
of all references in order to identify original research
reporting the incidence of LEA on the basis of inclusion
criteria. We will exclude at this stage those studies that are
clearly not population-based, or are randomized controlled
trials, or which include only traumatic or tumor-related
amputations, or report only the prevalence of amputations.
Subsequently, two reviewers will independently screen the
full-text articles of abstracts identified in the first phase.
We will include original full-text articles if they meet
the inclusion criteria with respect to types of study, types
of population, and the main outcome, regardless of the
time period and year of publication of the study, defin-
ition of LEA, type of diabetes, age and sex distribution,
and ethnicity. We will exclude studies if they report
solely incidences of LEA among persons with DM refer-
ring to the total population (diabetic and non-diabetic)
and not exclusively to the diabetic population. We also
will exclude studies if they are published in a language
other than English.
We will resolve disagreements pertaining to the inclu-
sion of articles by consensus, involving of a third party if
necessary.
Data collection process
First, we will develop a data extraction sheet (based on
the Cochrane Consumers and Communication ReviewGroup’s data extraction template [15]). After that, we
will carry out a pilot test using five randomly selected,
included papers and then will refine the data extraction
sheet accordingly. One review author will extract the fol-
lowing data from included articles, and the second au-
thor will check the extracted data. The two review
authors will resolve disagreements by discussion; if no
agreement can be reached, we plan to involve a third au-
thor who will then make a decision. We will use the
most comprehensive data if several articles report data
from the same study. We will contact the authors of
included studies for explanation of anything that is
unclear.
Data items
We will extract the following information from each in-
cluded article: (1) sources of data, (2) study design and
study period, (3) populations (diabetic and non-diabetic
population) and number at risk, (4) definitions of event
(LEA) including reported incidence as well as severity
criteria for amputations (major, minor, total), (5) type of
diabetes (T1DM, T2DM, other types, all DM without
distinguishing), and (6) absolute numbers and incidences
of LEA.
Data description
In studies with sufficient information on incident amputa-
tions, we will assess the outcomes of interest dependent
on reported incidence measures (IR or CumI), relative risk
of amputations comparing the diabetic to non-diabetic
populations, cause of LEA, and type of diabetes. We will
recalculate the reported IR per 100.000 person-years, if
originally not reported as such.
We will categorize the following specific IRs: (1) am-
putations in individuals with diabetes among the popula-
tion with diabetes, in comparison with (2) amputations
in individuals without diabetes in the population without
diabetes. Additionally, we will assign selected studies
into three groups: (1) studies that count only the first or
most severe observed amputation i.e., one amputation
per person would be carried out, (2) studies reporting
incidence of LEA on the basis of hospital data, and (3)
studies counting all amputations.
Statistical methods
From previous experience with a similar review [16–18],
we expect studies to be too heterogeneous to allow for a
quantitative summary of results. If, however, we find
subsets of studies to be homogeneous enough, we will
perform meta-analyses for incidence rates by Poisson
generalized linear mixed models (GLMM) as recom-
mended by Trikalinos et al. [19]. To account for estima-
tion uncertainty, all statistical estimates will be given their
95 % confidence intervals. In any case, heterogeneity will
Table 1 Assessment of risk of bias (adapted to Cochrane approach Study Quality Guide [20])
Assessment items Lower risk of bias Higher risk of bias
Measurement and definition of outcomes
LEA
Precise definition and description of how the LEA were
recorded
No definition and description of how the LEA
were recorded
Diagnostic criteria of diabetes Documented by physician (clinical diagnosis, ICD) Self-reported DM
Statistical methods: IR, CumI, RR Presented as age-sex adjusted estimates; reported with CI Crude rates; reported without CI
Time trends Time trends reported using multivariate regression models Time trends reported only descriptive
Duration of the observation perioda 5 years and more Less than 5 years
CI confidence interval, CumI cumulative incidence, DM diabetes mellitus, ICD International Statistical Classification of Diseases and Related Health Problems,
IR incidence rate, RR relative risk
aRelevant for studies reporting time trend
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prior statistical tests for homogeneity.
Data quality
Two independent reviewers will evaluate the quality of
the included studies using the Cochrane approach study
quality guide [20].
Assessment of risk of bias in individual studies
The reviewer NM will rate the quality of the individual
studies while reviewer KT will verify it.
Outcome and study level
For each included study, we will assess features that
could potentially bias the estimates of LEA. Using this
tool, we will rank potential sources of bias into low or
high risk of bias according to the recommendations of
the Cochrane approach (Table 1 [20]).
Discussion
We will perform the proposed systematic review to
analyze the incidence of LEA in the diabetic population
and to compare incidence rates in the diabetic and non-
diabetic population.
One strength of this review is that the selection of
studies will be based on a systematic search approach
according to a predetermined protocol including clearly
determined search strategies. Furthermore, we will use
an extraction sheet based on the Cochrane Consumers
and Communication Review Group’s data extraction
template.
In conclusion, this review will help to summarize the
available evidence for incidence of LEA. The publication
of this protocol will contribute to making the search
strategy, methods, and assessment of reviews transparent
and accessible for all involved professional groups.Additional file
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